Ovarian Cancer High-grade Serous Carcinoma

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer [Phase 1]

  This clinical trial update describes a Phase 1 study investigating the combination of trastuzumab deruxtecan (DS-8201a) and olaparib in HER2…